▶ 調査レポート

急性片頭痛治療薬のグローバル販売市場 2020年

• 英文タイトル:Global Acute Migraine Drugs Sales Market Report 2020
• レポートコード:MRC2102QY0141
• 出版社/出版日:QYResearch / 2021年1月
• レポート形態:英文、PDF、139ページ
• 納品方法:Eメール(受注後2~3営業日)
• 産業分類:医薬品、医療
• 販売価格(消費税別)
  Single User¥528,000 (USD4,000)▷ お問い合わせ
  Multi User¥792,000 (USD6,000)▷ お問い合わせ
  Enterprise License¥1,056,000 (USD8,000)▷ お問い合わせ
• ご注文方法:お問い合わせフォーム記入又はEメールでご連絡ください。
• お支払方法:銀行振込(納品後、ご請求書送付)
レポート概要
QYリサーチ社の本調査レポートでは、世界の急性片頭痛治療薬市場について種類別(トリプタン、NSAID、その他)、用途別(病院薬局、ドラッグストア)、地域別(米国、ヨーロッパ、中国、日本、東南アジア、インド)に区分して調査し、纏めました。2015年~2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。
・急性片頭痛治療薬市場の概要
・世界の主要地域別急性片頭痛治療薬市場規模2015-2026
・主要プレイヤーの競争状況・市場シェア
・世界の急性片頭痛治療薬市場規模2015-2026:種類別(トリプタン、NSAID、その他)
・世界の急性片頭痛治療薬市場規模2015-2026:用途別(病院薬局、ドラッグストア)
・急性片頭痛治療薬の米国市場規模2015-2020
・急性片頭痛治療薬のヨーロッパ市場規模2015-2020
・急性片頭痛治療薬の中国市場規模2015-2020
・急性片頭痛治療薬の日本市場規模2015-2020
・急性片頭痛治療薬の東南アジア市場規模2015-2020
・急性片頭痛治療薬のインド市場規模2015-2020
・主要プレイヤーの企業情報:事業概要・売上・企業動向
・急性片頭痛治療薬の製造コスト分析
・販売チャネル、流通業者、顧客
・急性片頭痛治療薬の市場動向・機会・課題
・調査の結論

A migraine is an episodic and unpredictable headache disorder that presents with disabling attack. Migraine is one of the most frequent disabling neurological conditions with a major impact on the patient’s quality of life. Migraine has been described as a chronic disorder that characterized with attacks. Attacks are characterized by moderate–severe, often unilateral, pulsating headache attacks, typically lasting 4 to 72 hours.
The top 3 manufacturers held about 29.5% of the market share in 2019, while top 5 hold 41.93%.

Market Analysis and Insights: Global Acute Migraine Drugs Market
The global Acute Migraine Drugs market size is projected to reach US$ 2993.2 million by 2026, from US$ 1956.9 million in 2020, at a CAGR of 7.3% during 2021-2026.

Global Acute Migraine Drugs Scope and Market Size
The global Acute Migraine Drugs market is segmented by company, region (country), by Type, and by Application. Players, stakeholders, and other participants in the global Acute Migraine Drugs market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on sales, revenue and forecast by region (country), by Type and by Application for the period 2015-2026.

Segment by Type, the Acute Migraine Drugs market is segmented into
Triptans
NSAIDs
Others
The proportion of triptans in 2019 is about 79.59% market share.

Segment by Application, the Acute Migraine Drugs market is segmented into
Hospital Pharmacies
Drug Stores
The proportion of hospitals in 2019 is about 62.93%.

The Acute Migraine Drugs market is analysed and market size information is provided by regions (countries). Segment by Application, the Acute Migraine Drugs market is segmented into United States, Europe, China, Japan, Southeast Asia, India and Rest of World.
The report includes region-wise market size for the period 2015-2026. It also includes market size and forecast by players, by Type, and by Application segment in terms of sales and revenue for the period 2015-2026.

Competitive Landscape and Acute Migraine Drugs Market Share Analysis
Acute Migraine Drugs market competitive landscape provides details and data information by players. The report offers comprehensive analysis and accurate statistics on revenue by the player for the period 2015-2020. It also offers detailed analysis supported by reliable statistics on revenue (global and regional level) by players for the period 2015-2020. Details included are company description, major business, company total revenue and the sales, revenue generated in Acute Migraine Drugs business, the date to enter into the Acute Migraine Drugs market, Acute Migraine Drugs product introduction, recent developments, etc.

The major vendors covered:
GSK
Teva
Pfizer
Novartis
Sun Pharma
Grunenthal
Endo Pharmaceuticals
Merck
J & J

レポート目次

1 Acute Migraine Drugs Market Overview
1.1 Acute Migraine Drugs Product Scope
1.2 Acute Migraine Drugs Segment by Type
1.2.1 Global Acute Migraine Drugs Sales by Type (2020-2026)
1.2.2 Triptans
1.2.3 NSAIDs
1.2.4 Others
1.3 Acute Migraine Drugs Segment by Application
1.3.1 Global Acute Migraine Drugs Sales Comparison by Application (2020-2026)
1.3.2 Hospital Pharmacies
1.3.3 Drug Stores
1.4 Acute Migraine Drugs Market Estimates and Forecasts (2015-2026)
1.4.1 Global Acute Migraine Drugs Sales Growth Rate (2015-2026)
1.4.2 Global Acute Migraine Drugs Revenue and Growth Rate (2015-2026)
1.4.3 Global Acute Migraine Drugs Price Trends (2015-2026)

2 Acute Migraine Drugs Estimate and Forecast by Region
2.1 Global Acute Migraine Drugs Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Acute Migraine Drugs Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Acute Migraine Drugs Sales Market Share by Region (2015-2020)
2.2.2 Global Acute Migraine Drugs Revenue Market Share by Region (2015-2020)
2.3 Global Acute Migraine Drugs Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Acute Migraine Drugs Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Acute Migraine Drugs Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Acute Migraine Drugs Estimates and Projections (2015-2026)
2.4.2 Europe Acute Migraine Drugs Estimates and Projections (2015-2026)
2.4.3 China Acute Migraine Drugs Estimates and Projections (2015-2026)
2.4.4 Japan Acute Migraine Drugs Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Acute Migraine Drugs Estimates and Projections (2015-2026)
2.4.6 India Acute Migraine Drugs Estimates and Projections (2015-2026)
3 Global Acute Migraine Drugs Competition Landscape by Players
3.1 Global Top Acute Migraine Drugs Players by Sales (2015-2020)
3.2 Global Top Acute Migraine Drugs Players by Revenue (2015-2020)
3.3 Global Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Migraine Drugs as of 2019)
3.4 Global Acute Migraine Drugs Average Price by Company (2015-2020)
3.5 Manufacturers Acute Migraine Drugs Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Acute Migraine Drugs Players (Opinion Leaders)
4 Global Acute Migraine Drugs Market Size by Type
4.1 Global Acute Migraine Drugs Historic Market Review by Type (2015-2020)
4.1.1 Global Acute Migraine Drugs Sales Market Share by Type (2015-2020)
4.1.2 Global Acute Migraine Drugs Revenue Market Share by Type (2015-2020)
4.1.3 Global Acute Migraine Drugs Price by Type (2015-2020)
4.2 Global Acute Migraine Drugs Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Acute Migraine Drugs Sales Forecast by Type (2021-2026)
4.2.2 Global Acute Migraine Drugs Revenue Forecast by Type (2021-2026)
4.2.3 Global Acute Migraine Drugs Price Forecast by Type (2021-2026)
5 Global Acute Migraine Drugs Market Size by Application
5.1 Global Acute Migraine Drugs Historic Market Review by Application (2015-2020)
5.1.1 Global Acute Migraine Drugs Sales Market Share by Application (2015-2020)
5.1.2 Global Acute Migraine Drugs Revenue Market Share by Application (2015-2020)
5.1.3 Global Acute Migraine Drugs Price by Application (2015-2020)
5.2 Global Acute Migraine Drugs Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Acute Migraine Drugs Sales Forecast by Application (2021-2026)
5.2.2 Global Acute Migraine Drugs Revenue Forecast by Application (2021-2026)
5.2.3 Global Acute Migraine Drugs Price Forecast by Application (2021-2026)

6 United States Acute Migraine Drugs Market Facts & Figures
6.1 United States Acute Migraine Drugs Sales Market Share by Company (2015-2020)
6.2 United States Acute Migraine Drugs Sales Market Share by Type (2015-2020)
6.3 United States Acute Migraine Drugs Sales Market Share by Application (2015-2020)

7 Europe Acute Migraine Drugs Market Facts & Figures
7.1 Europe Acute Migraine Drugs Sales Market Share by Company (2015-2020)
7.2 Europe Acute Migraine Drugs Sales Market Share by Type (2015-2020)
7.3 Europe Acute Migraine Drugs Sales Market Share by Application (2015-2020)

8 China Acute Migraine Drugs Market Facts & Figures
8.1 China Acute Migraine Drugs Sales Market Share by Company (2015-2020)
8.2 China Acute Migraine Drugs Sales Market Share by Type (2015-2020)
8.3 China Acute Migraine Drugs Sales Market Share by Application (2015-2020)

9 Japan Acute Migraine Drugs Market Facts & Figures
9.1 Japan Acute Migraine Drugs Sales Market Share by Company (3015-3030)
9.2 Japan Acute Migraine Drugs Sales Market Share by Type (2015-2020)
9.3 Japan Acute Migraine Drugs Sales Market Share by Application (2015-2020)

10 Southeast Asia Acute Migraine Drugs Market Facts & Figures
10.1 Southeast Asia Acute Migraine Drugs Sales Market Share by Company (2015-2020)
10.2 Southeast Asia Acute Migraine Drugs Sales Market Share by Type (2015-2020)
10.3 Southeast Asia Acute Migraine Drugs Sales Market Share by Application (2015-2020)

11 India Acute Migraine Drugs Market Facts & Figures
11.1 India Acute Migraine Drugs Sales Market Share by Company (2015-2020)
11.2 India Acute Migraine Drugs Sales Market Share by Type (2015-2020)
11.3 India Acute Migraine Drugs Sales Market Share by Application (2015-2020)

12 Company Profiles and Key Figures in Acute Migraine Drugs Business
12.1 GSK
12.1.1 GSK Corporation Information
12.1.2 GSK Business Overview
12.1.3 GSK Acute Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.1.4 GSK Acute Migraine Drugs Products Offered
12.1.5 GSK Recent Development
12.2 Teva
12.2.1 Teva Corporation Information
12.2.2 Teva Business Overview
12.2.3 Teva Acute Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.2.4 Teva Acute Migraine Drugs Products Offered
12.2.5 Teva Recent Development
12.3 Pfizer
12.3.1 Pfizer Corporation Information
12.3.2 Pfizer Business Overview
12.3.3 Pfizer Acute Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Pfizer Acute Migraine Drugs Products Offered
12.3.5 Pfizer Recent Development
12.4 Novartis
12.4.1 Novartis Corporation Information
12.4.2 Novartis Business Overview
12.4.3 Novartis Acute Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.4.4 Novartis Acute Migraine Drugs Products Offered
12.4.5 Novartis Recent Development
12.5 Sun Pharma
12.5.1 Sun Pharma Corporation Information
12.5.2 Sun Pharma Business Overview
12.5.3 Sun Pharma Acute Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Sun Pharma Acute Migraine Drugs Products Offered
12.5.5 Sun Pharma Recent Development
12.6 Grunenthal
12.6.1 Grunenthal Corporation Information
12.6.2 Grunenthal Business Overview
12.6.3 Grunenthal Acute Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.6.4 Grunenthal Acute Migraine Drugs Products Offered
12.6.5 Grunenthal Recent Development
12.7 Endo Pharmaceuticals
12.7.1 Endo Pharmaceuticals Corporation Information
12.7.2 Endo Pharmaceuticals Business Overview
12.7.3 Endo Pharmaceuticals Acute Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Endo Pharmaceuticals Acute Migraine Drugs Products Offered
12.7.5 Endo Pharmaceuticals Recent Development
12.8 Merck
12.8.1 Merck Corporation Information
12.8.2 Merck Business Overview
12.8.3 Merck Acute Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Merck Acute Migraine Drugs Products Offered
12.8.5 Merck Recent Development
12.9 J & J
12.9.1 J & J Corporation Information
12.9.2 J & J Business Overview
12.9.3 J & J Acute Migraine Drugs Sales, Revenue and Gross Margin (2015-2020)
12.9.4 J & J Acute Migraine Drugs Products Offered
12.9.5 J & J Recent Development

13 Acute Migraine Drugs Manufacturing Cost Analysis
13.1 Acute Migraine Drugs Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Acute Migraine Drugs
13.4 Acute Migraine Drugs Industrial Chain Analysis

14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Acute Migraine Drugs Distributors List
14.3 Acute Migraine Drugs Customers

15 Market Dynamics
15.1 Acute Migraine Drugs Market Trends
15.2 Acute Migraine Drugs Opportunities and Drivers
15.3 Acute Migraine Drugs Market Challenges
15.4 Acute Migraine Drugs Market Restraints
15.5 Porter’s Five Forces Analysis

16 Research Findings and Conclusion

17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer

List of Tables
Table 1. Global Acute Migraine Drugs Sales (K Unit) Growth Rate by Type (2020-2026) (US$ Million)
Table 2. Global Acute Migraine Drugs Sales (K Unit) Comparison by Application (2020-2026) (US$ Million)
Table 3. Global Market Acute Migraine Drugs Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 4. Global Acute Migraine Drugs Sales (K Unit) by Region (2015-2020)
Table 5. Global Acute Migraine Drugs Sales Market Share by Region (2015-2020)
Table 6. Global Acute Migraine Drugs Revenue (US$ Million) Market Share by Region (2015-2020))
Table 7. Global Acute Migraine Drugs Revenue Share by Region (2015-2020)
Table 8. Global Acute Migraine Drugs Sales (K Unit) Forecast by Region (2021-2026)
Table 9. Global Acute Migraine Drugs Sales Market Share Forecast by Region (2021-2026)
Table 10. Global Acute Migraine Drugs Revenue (US$ Million) Forecast by Region (2021-2026)
Table 11. Global Acute Migraine Drugs Revenue Share Forecast by Region (2021-2026)
Table 12. Global Acute Migraine Drugs (K Unit) of Key Companies (2015-2020)
Table 13. Global Acute Migraine Drugs Sales Share by Company (2015-2020)
Table 14. Global Acute Migraine Drugs Revenue (US$ Million) by Company (2015-2020)
Table 15. Global Acute Migraine Drugs Revenue Share by Company (2015-2020)
Table 16. Global Acute Migraine Drugs by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Acute Migraine Drugs as of 2019)
Table 17. Global Acute Migraine Drugs Average Price (USD/Unit) of Key Company (2015-2020)
Table 18. Manufacturers Acute Migraine Drugs Manufacturing Sites and Area Served
Table 19. Manufacturers Acute Migraine Drugs Product Type
Table 20. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 21. Main Points Interviewed from Key Acute Migraine Drugs Players
Table 22. Global Acute Migraine Drugs Sales (K Unit) by Type (2015-2020)
Table 23. Global Acute Migraine Drugs Sales Share by Type (2015-2020)
Table 24. Global Acute Migraine Drugs Revenue (US$ Million) Market Share by Type (2015-2020)
Table 25. Global Acute Migraine Drugs Price (K Unit) by Type (2015-2020)
Table 26. Global Acute Migraine Drugs Sales Share by Type (2021-2026)
Table 27. Global Acute Migraine Drugs Revenue (US$ Million) Market Share by Type (2021-2026)
Table 28. Global Acute Migraine Drugs Revenue Share by Type (2021-2026)
Table 29. Global Acute Migraine Drugs Price (K Unit) by Type (2021-2026)
Table 30. Global Acute Migraine Drugs Sales (K Unit) by Application (2015-2020)
Table 31. Global Acute Migraine Drugs Sales Share by Application (2015-2020)
Table 32. Global Acute Migraine Drugs Revenue (US$ Million) Market Share by Application (2015-2020)
Table 33. Global Acute Migraine Drugs Price (K Unit) by Application (2015-2020)
Table 34. Global Acute Migraine Drugs Sales (K Unit) by Application (2021-2026)
Table 35. Global Acute Migraine Drugs Sales Share by Application (2021-2026)
Table 36. Global Acute Migraine Drugs Revenue (US$ Million) Market Share by Application (2021-2026)
Table 37. Global Acute Migraine Drugs Revenue Share by Application (2021-2026)
Table 38. Global Acute Migraine Drugs Price (K Unit) by Application (2021-2026)
Table 39. United States Acute Migraine Drugs Sales (K Unit) by Company (2015-2020)
Table 40. United States Acute Migraine Drugs Sales Market Share by Company (2015-2020)
Table 41. United States Acute Migraine Drugs Sales (K Unit) by Type (2015-2020)
Table 42. United States Acute Migraine Drugs Sales Market Share by Type (2015-2020)
Table 43. United States Acute Migraine Drugs Sales (K Unit) by Application (2015-2020)
Table 44. United States Acute Migraine Drugs Sales Market Share by Application (2015-2020)
Table 45. Europe Acute Migraine Drugs Sales (K Unit) by Company (2015-2020)
Table 46. Europe Acute Migraine Drugs Sales Market Share by Company (2015-2020)
Table 47. Europe Acute Migraine Drugs Sales (K Unit) by Type (2015-2020)
Table 48. Europe Acute Migraine Drugs Sales Market Share by Type (2015-2020)
Table 49. Europe Acute Migraine Drugs Sales (K Unit) by Application (2015-2020)
Table 50. Europe Acute Migraine Drugs Sales Market Share by Type (2015-2020)
Table 51. China Acute Migraine Drugs Sales (K Unit) by Company (2015-2020)
Table 52. China Acute Migraine Drugs Sales Market Share by Company (2015-2020)
Table 53. China Acute Migraine Drugs Sales (K Unit) by Type (2015-2020)
Table 54. China Acute Migraine Drugs Sales Market Share by Type (2015-2020)
Table 55. China Acute Migraine Drugs Sales (K Unit) by Application (2015-2020)
Table 56. China Acute Migraine Drugs Sales Market Share by Application (2015-2020)
Table 57. Japan Acute Migraine Drugs Sales (K Unit) by Company (2015-2020)
Table 58. Japan Acute Migraine Drugs Sales Market Share by Company (2015-2020)
Table 59. Japan Acute Migraine Drugs Sales (K Unit) by Type (2015-2020)
Table 60. Japan Acute Migraine Drugs Sales Market Share by Type (2015-2020)
Table 61. Japan Acute Migraine Drugs Sales (K Unit) by Application (2015-2020)
Table 62. Japan Acute Migraine Drugs Sales Market Share by Application (2015-2020)
Table 63. Southeast Asia Acute Migraine Drugs Sales (K Unit) by Company (2015-2020)
Table 64. Southeast Asia Acute Migraine Drugs Sales Market Share by Company (2015-2020)
Table 65. Southeast Asia Acute Migraine Drugs Sales (K Unit) by Type (2015-2020)
Table 66. Southeast Asia Acute Migraine Drugs Sales Market Share by Type (2015-2020)
Table 67. Southeast Asia Acute Migraine Drugs Sales (K Unit) by Type (2015-2020)
Table 68. Southeast Asia Acute Migraine Drugs Sales Market Share by Application (2015-2020)
Table 69. India Acute Migraine Drugs Sales (K Unit) by Company (2015-2020)
Table 70. India Acute Migraine Drugs Sales Market Share by Company (2015-2020)
Table 71. India Acute Migraine Drugs Sales (K Unit) by Type (2015-2020)
Table 72. India Acute Migraine Drugs Sales Market Share by Type (2015-2020)
Table 73. India Acute Migraine Drugs Sales (K Unit) by Application (2015-2020)
Table 74. India Acute Migraine Drugs Sales Market Share by Application (2015-2020)
Table 75. GSK Corporation Information
Table 76. GSK Description and Business Overview
Table 77. GSK Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 78. GSK Acute Migraine Drugs Product
Table 79. GSK Recent Development
Table 80. Teva Corporation Information
Table 81. Teva Description and Business Overview
Table 82. Teva Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Teva Acute Migraine Drugs Product
Table 84. Teva Recent Development
Table 85. Pfizer Corporation Information
Table 86. Pfizer Description and Business Overview
Table 87. Pfizer Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. Pfizer Acute Migraine Drugs Product
Table 89. Pfizer Recent Development
Table 90. Novartis Corporation Information
Table 91. Novartis Description and Business Overview
Table 92. Novartis Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Novartis Acute Migraine Drugs Product
Table 94. Novartis Recent Development
Table 95. Sun Pharma Corporation Information
Table 96. Sun Pharma Description and Business Overview
Table 97. Sun Pharma Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. Sun Pharma Acute Migraine Drugs Product
Table 99. Sun Pharma Recent Development
Table 100. Grunenthal Corporation Information
Table 101. Grunenthal Description and Business Overview
Table 102. Grunenthal Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Grunenthal Acute Migraine Drugs Product
Table 104. Grunenthal Recent Development
Table 105. Endo Pharmaceuticals Corporation Information
Table 106. Endo Pharmaceuticals Description and Business Overview
Table 107. Endo Pharmaceuticals Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. Endo Pharmaceuticals Acute Migraine Drugs Product
Table 109. Endo Pharmaceuticals Recent Development
Table 110. Merck Corporation Information
Table 111. Merck Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 112. Merck Description and Business Overview
Table 113. Merck Acute Migraine Drugs Product
Table 114. Merck Recent Development
Table 115. J & J Corporation Information
Table 116. J & J Acute Migraine Drugs Sales (K Unit), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. J & J Description and Business Overview
Table 118. J & J Acute Migraine Drugs Product
Table 119. J & J Recent Development
Table 120. Production Base and Market Concentration Rate of Raw Material
Table 121. Key Suppliers of Raw Materials
Table 122. Acute Migraine Drugs Distributors List
Table 123. Acute Migraine Drugs Customers List
Table 124. Acute Migraine Drugs Market Key Trends
Table 125. Acute Migraine Drugs Key Opportunities and Drivers
Table 126. Acute Migraine Drugs Market Challenges
Table 127. Research Programs/Design for This Report
Table 128. Key Data Information from Secondary Sources
Table 129. Key Data Information from Primary Sources
List of Figures
Figure 1. Acute Migraine Drugs Product Picture
Figure 2. Global Acute Migraine Drugs Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Acute Migraine Drugs Market Share by Application in 2020 & 2026
Figure 6. Hospital Pharmacies Examples
Figure 7. Drug Stores Examples
Figure 8. Global Acute Migraine Drugs Sales (K Unit) Growth Rate (2015-2026)
Figure 9. Global Acute Migraine Drugs Revenue (US$ Million) Growth Rate (2015-2026)
Figure 10. Global Acute Migraine Drugs Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 11. Global Acute Migraine Drugs Revenue Market Share by Region: 2015 VS 2020
Figure 12. Global Acute Migraine Drugs Revenue Market Share by Region: 2021 VS 2026
Figure 13. United States Acute Migraine Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 14. United States Acute Migraine Drugs Sales (K Unit) Growth Rate (2015-2026)
Figure 15. Europe Acute Migraine Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. Europe Acute Migraine Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 17. China Acute Migraine Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. China Acute Migraine Drugs Sales (Million USD) and Growth Rate (2015-2026)
Figure 19. Japan Acute Migraine Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. Japan Acute Migraine Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 21. Southeast Asia Acute Migraine Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Southeast Asia Acute Migraine Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 23. India Acute Migraine Drugs Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. India Acute Migraine Drugs Sales (Million USD) Growth Rate (2015-2026)
Figure 25. Global 5 Largest Acute Migraine Drugs Players Market Share by Revenue in Acute Migraine Drugs 2015 & 2019
Figure 26. Acute Migraine Drugs Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 27. Global Acute Migraine Drugs Revenue Share by Type (2015-2020)
Figure 28. Global Acute Migraine Drugs Revenue Growth Rate by Type in 2015 & 2019
Figure 29. Global Acute Migraine Drugs Revenue Share by Application (2015-2020)
Figure 30. Global Acute Migraine Drugs Revenue Growth Rate by Application in 2015 & 2019
Figure 31. United States Acute Migraine Drugs Sales Market Share by Type in 2019
Figure 32. United States Acute Migraine Drugs Sales Market Share by Type in 2019
Figure 33. Europe Acute Migraine Drugs Sales Market Share by Company in 2019
Figure 34. Europe Acute Migraine Drugs Sales Market Share by Type in 2019
Figure 35. Europe Acute Migraine Drugs Sales Market Share by Application in 2019
Figure 36. China Acute Migraine Drugs Sales Market Share by Company in 2019
Figure 37. China Acute Migraine Drugs Sales Market Share by Type in 2019
Figure 38. China Acute Migraine Drugs Sales Market Share by Application in 2019
Figure 39. Japan Acute Migraine Drugs Sales Market Share by Company in 2019
Figure 40. Japan Acute Migraine Drugs Sales Market Share by Type in 2019
Figure 41. Japan Acute Migraine Drugs Sales Market Share by Application in 2019
Figure 42. Southeast Asia Acute Migraine Drugs Sales Market Share by Company in 2019
Figure 43. Southeast Asia Acute Migraine Drugs Sales Market Share by Type in 2019
Figure 44. Southeast Asia Acute Migraine Drugs Sales Market Share by Application in 2019
Figure 45. India Acute Migraine Drugs Sales Market Share by Company in 2019
Figure 46. India Acute Migraine Drugs Sales Market Share by Type in 2019
Figure 47. India Acute Migraine Drugs Sales Market Share by Application in 2019
Figure 48. Key Raw Materials Price Trend
Figure 49. Manufacturing Cost Structure of Acute Migraine Drugs
Figure 50. Manufacturing Process Analysis of Acute Migraine Drugs
Figure 51. Acute Migraine Drugs Industrial Chain Analysis
Figure 52. Channels of Distribution
Figure 53. Distributors Profiles
Figure 54. Porter's Five Forces Analysis
Figure 55. Bottom-up and Top-down Approaches for This Report
Figure 56. Data Triangulation
Figure 57. Key Executives Interviewed



• 英文レポート名:Global Acute Migraine Drugs Sales Market Report 2020
• 日本語訳:急性片頭痛治療薬のグローバル販売市場 2020年
• レポートコード:MRC2102QY0141お問い合わせ(見積依頼・ご注文・質問)